pI: 4.9313 |
Length (AA): 367 |
MW (Da): 40616 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 359 | 1qs0 (A) | 35 | 408 | 32.00 | 0 | 1 | 1.3491 | -0.42 |
13 | 365 | 1w85 (A) | 16 | 368 | 36.00 | 0 | 1 | 1.43645 | -0.75 |
18 | 363 | 1um9 (A) | 14 | 367 | 40.00 | 0 | 1 | 1.26568 | 0.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase, Dormant phase. | hasan murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_128261)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G09300 | thiamin diphosphate-binding fold (THDP-binding) domain-containing protein |
Arabidopsis thaliana | AT1G21400 | thiamin diphosphate-binding fold protein |
Babesia bovis | BBOV_III008200 | dehydrogenase E1 component family protein |
Brugia malayi | Bm1_00280 | 2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor |
Caenorhabditis elegans | CELE_Y39E4A.3 | Protein Y39E4A.3, isoform A |
Dictyostelium discoideum | DDB_G0286335 | 3-methyl-2-oxobutanoate dehydrogenase |
Drosophila melanogaster | Dmel_CG8199 | CG8199 gene product from transcript CG8199-RA |
Homo sapiens | ENSG00000248098 | branched chain keto acid dehydrogenase E1, alpha polypeptide |
Leishmania braziliensis | LbrM.21.1810 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Leishmania donovani | LdBPK_211670.1 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Leishmania infantum | LinJ.21.1670 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Leishmania major | LmjF.21.1430 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Leishmania mexicana | LmxM.21.1430 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Loa Loa (eye worm) | LOAG_02337 | 2-oxoisovalerate dehydrogenase alpha subunit |
Mus musculus | ENSMUSG00000060376 | branched chain ketoacid dehydrogenase E1, alpha polypeptide |
Mycobacterium tuberculosis | Rv2497c | Probable branched-chain keto acid dehydrogenase E1 component, alpha subunit BkdA |
Mycobacterium ulcerans | MUL_3775 | pyruvate dehydrogenase E1 component subunit PdhA |
Neospora caninum | NCLIV_016110 | hypothetical protein |
Neospora caninum | NCLIV_012850 | hypothetical protein |
Oryza sativa | 4351684 | Os12g0183100 |
Onchocerca volvulus | OVOC9485 | Bckdha protein homolog |
Plasmodium berghei | PBANKA_1411100 | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial |
Plasmodium falciparum | PF3D7_1312600 | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative |
Plasmodium knowlesi | PKNH_1413300 | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative |
Plasmodium vivax | PVX_122460 | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, putative |
Plasmodium yoelii | PY05086 | branched-chain alpha-keto acid dehydrogenase E1-alpha subunit |
Schmidtea mediterranea | mk4.002135.04 | |
Schmidtea mediterranea | mk4.021022.00 | |
Schmidtea mediterranea | mk4.002323.03 | Bckdha protein |
Schmidtea mediterranea | mk4.031844.00 | |
Schmidtea mediterranea | mk4.002135.02 | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial |
Schmidtea mediterranea | mk4.031108.01 | |
Schmidtea mediterranea | mk4.021158.03 | |
Schmidtea mediterranea | mk4.017274.02 | Bckdha protein |
Trypanosoma brucei gambiense | Tbg972.10.680 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Trypanosoma brucei | Tb927.10.660 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Trypanosoma congolense | TcIL3000_10_520 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Trypanosoma cruzi | TcCLB.506853.50 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Trypanosoma cruzi | TcCLB.508781.110 | 2-oxoisovalerate dehydrogenase alpha subunit, putative |
Toxoplasma gondii | TGME49_292100 | 2-oxoisovalerate dehydrogenase subunit alpha, putative |
Toxoplasma gondii | TGME49_239490 | dehydrogenase E1 component family protein |
Theileria parva | TP04_0719 | branched-chain alpha keto-acid dehydrogenase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2540 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.10.660 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.660 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.660 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.660 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1411100 | Plasmodium berghei | Slow | plasmo |
TGME49_239490 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_292100 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_239490 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_292100 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.